Study Identifies Unpredicted Immune Responses to Adenoviral COVID Vaccines
July 19, 2024
July 19, 2024
LIVERPOOL, England, July 19 (TNSres) -- The University of Liverpool issued the following news release:
Researchers from the University of Liverpool's Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
Using blood samples from healthy participants collected ten years prior to the COVID-19 pandemic, and therefore before any of the COVID- . . .
Researchers from the University of Liverpool's Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines, but not to the mRNA vaccines.
Using blood samples from healthy participants collected ten years prior to the COVID-19 pandemic, and therefore before any of the COVID- . . .